genOway Société anonyme (ALGEN.PA)

EUR 3.92

(0.0%)

Long Term Debt Summary of genOway Société anonyme

  • genOway Société anonyme's latest annual long term debt in 2023 was 5.51 Million EUR , down -23.35% from previous year.
  • genOway Société anonyme's latest quarterly long term debt in 2023 FY was 5.51 Million EUR , down -23.35% from previous quarter.
  • genOway Société anonyme reported annual long term debt of 7.2 Million EUR in 2022, down -19.95% from previous year.
  • genOway Société anonyme reported annual long term debt of 8.99 Million EUR in 2021, down -10.18% from previous year.
  • genOway Société anonyme reported quarterly long term debt of 6.04 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • genOway Société anonyme reported quarterly long term debt of 5.51 Million EUR for 2023 FY, down -23.35% from previous quarter.

Annual Long Term Debt Chart of genOway Société anonyme (2023 - 2009)

Historical Annual Long Term Debt of genOway Société anonyme (2023 - 2009)

Year Long Term Debt Long Term Debt Growth
2023 5.51 Million EUR -23.35%
2022 7.2 Million EUR -19.95%
2021 8.99 Million EUR -10.18%
2020 10.01 Million EUR 90.22%
2019 5.26 Million EUR 12.99%
2018 4.65 Million EUR 24.86%
2017 3.73 Million EUR 0.0%
2016 - EUR 0.0%
2015 - EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%
2011 - EUR 0.0%
2010 - EUR 0.0%
2009 - EUR 0.0%

Peer Long Term Debt Comparison of genOway Société anonyme

Name Long Term Debt Long Term Debt Difference
ABIONYX Pharma SA 1.1 Million EUR -401.299%
ABIVAX Société Anonyme 44.69 Million EUR 87.652%
Adocia SA 4.54 Million EUR -21.571%
Aelis Farma SA 2.04 Million EUR -169.497%
Biophytis S.A. 3.11 Million EUR -77.412%
Advicenne S.A. 15.89 Million EUR 65.279%
IntegraGen SA 642.28 Thousand EUR -759.329%
Medesis Pharma S.A. 1.2 Million EUR -359.942%
Neovacs S.A. 650 Thousand EUR -749.123%
NFL Biosciences SA 39.2 Thousand EUR -13978.772%
Plant Advanced Technologies SA 4.35 Million EUR -26.691%
Quantum Genomics Société Anonyme 1.96 Million EUR -181.55%
Sensorion SA 1.24 Million EUR -344.778%
Theranexus Société Anonyme 2.46 Million EUR -124.296%
TME Pharma N.V. - EUR -Infinity%
Valbiotis SA 3.89 Million EUR -41.593%
TheraVet SA 1 Million EUR -451.6%
Valerio Therapeutics Société anonyme 6.9 Million EUR 20.08%
argenx SE 15.35 Million EUR 64.053%
BioSenic S.A. 15.57 Million EUR 64.559%
Celyad Oncology SA 902 Thousand EUR -511.896%
DBV Technologies S.A. 4.52 Million USD -21.947%
Galapagos NV 4.94 Million EUR -11.636%
Genfit S.A. 62.25 Million EUR 91.134%
GeNeuro SA 6.49 Million EUR 14.987%
Hyloris Pharmaceuticals SA 344 Thousand EUR -1504.448%
Innate Pharma S.A. 30.6 Million EUR 81.967%
Inventiva S.A. 25.61 Million EUR 78.454%
MaaT Pharma SA 5.42 Million EUR -1.738%
MedinCell S.A. 52.8 Million EUR 89.547%
Nanobiotix S.A. 41.66 Million EUR 86.752%
Onward Medical N.V. 16.3 Million EUR 66.152%
Oryzon Genomics S.A. 3.45 Million EUR -59.951%
OSE Immunotherapeutics SA 35.5 Million EUR 84.456%
Oxurion NV 117 Thousand EUR -4617.351%
Pharming Group N.V. 123.65 Million EUR 95.537%
Poxel S.A. 40.14 Million EUR 86.251%
GenSight Biologics S.A. 1.04 Million EUR -426.651%
Transgene SA 17 Thousand EUR -32366.476%
Financière de Tubize SA - EUR -Infinity%
UCB SA 2.87 Billion EUR 99.808%
Valneva SE 132.76 Million EUR 95.843%
Vivoryon Therapeutics N.V. - EUR -Infinity%